|
|
|
|
|
|
|
reduce costs, 78 percent to improve their product quality, and 67 percent to improve delivery times. |
|
|
|
|
|
|
|
|
The CRO industry provides a service to pharmaceutical companies and is expected by their clients to address those very issues said to be improved in the survey cited of companies in other industries which have introduced preferred partnerships. There is, therefore, a good case for considering such partnerships between a pharmaceutical company and a number of selected and evaluated CROs. |
|
|
|
|
|
|
|
|
|
The benefits to the CRO which are central to the formation of preferred partnerships with a number of clients are |
|
|
|
| |
|
|
|
|
The benefits sought by a pharmaceutical company from a preferred partner are |
|
|
|
|  |
|
|
|
|
1. to obtain a secure cash flow |
|
|
|
|
|
|
|
|
2. to reduce the administrative burden of bidding and negotiation for contracts awarded elsewhere |
|
|
|
|
|
|
|
|
3. to improve forward planning, work scheduling, staff allocation, and recruitment |
|
|
|
|
|
|
|
|
4. to reduce advertising and business development costs |
|
|
|
|
|
|
|
|
5. to enhance staff job satisfaction by being part of a team with the client |
|
|
|
| |
|
|
|
|
1. predictable prices and payment terms |
|
|
|
|
|
|
|
|
2. guaranteed high quality work with emphasis on improvement |
|
|
|
|
|
|
|
|
3. reduced administrative time relating to CRO selection for studies |
|
|
|
|
|
|
|
|
4. dedicated staff for projects |
|
|
|
|
|
|
|
|
5. reduced time to set up studies |
|
|
|
|
|
|
|
|
6. reduced time to complete studies |
|
|
|
|
|
|
|
|
7. innovation in clinical trial processes leading to reduced timing and improved quality |
|
|
|
|
|
|
|
|
|
|
The Preferred Partnership concept is driven by three simple goals: |
|
|
|
|
|
|
|
|
increased performance,
reduction in costs, and
innovation. |
|
|
|
|
|
|
|
|
However, the substantial gains to be made from these arrangements will not be forthcoming unless a considerable effort is made by both parties |
|
|
|
|
|